US5300302A
(en)
*
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
MX9304638A
(es)
*
|
1992-07-31 |
1994-05-31 |
Neose Pharm Inc |
Composicion para tratar e inhibir las ulceras gastricas y duodenales.
|
JPH06172189A
(ja)
*
|
1992-08-17 |
1994-06-21 |
Bristol Myers Squibb Co |
胃腸保護複合剤
|
US5881926A
(en)
*
|
1993-03-11 |
1999-03-16 |
Taro Pharmaceutical Industries, Ltd. |
Pharmaceutical compositions in semisolid form and a device for administration thereof
|
IL108366A
(en)
*
|
1993-03-11 |
1999-11-30 |
Taro Vit Ind Ltd |
Semi-solid pharmaceutical compounds and a device for their use
|
AU3896395A
(en)
*
|
1994-10-11 |
1996-05-02 |
James A. Monson |
Dispensing apparatus for foaming compositions and method
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
US6709678B2
(en)
*
|
1996-08-15 |
2004-03-23 |
Losan Pharma Gmbh |
Easy to swallow oral medicament composition
|
US5759579A
(en)
*
|
1996-12-05 |
1998-06-02 |
American Home Products Corporation |
Pharmaceutical suspension systems
|
GB9720061D0
(en)
|
1997-09-19 |
1997-11-19 |
Crosfield Joseph & Sons |
Metal compounds as phosphate binders
|
US6071523A
(en)
|
1998-06-03 |
2000-06-06 |
Taro Pharmaceuticals Industries, Ltd. |
Spill resistant pharmaceutical compositions in semi-solid form
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
KR100399483B1
(ko)
*
|
2000-12-12 |
2003-09-29 |
대화제약 주식회사 |
플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
|
KR100759635B1
(ko)
*
|
2001-06-22 |
2007-09-17 |
화이자 프로덕츠 인코포레이티드 |
비정질 약물의 흡착체의 약학 조성물
|
ES2323264T3
(es)
*
|
2001-08-01 |
2009-07-10 |
Novartis Ag |
Composicion para enmascaramiento del sabor.
|
US7638150B2
(en)
*
|
2002-08-02 |
2009-12-29 |
Simply Thick Llp |
Process for preparing concentrate thickener compositions
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030235618A1
(en)
*
|
2001-10-22 |
2003-12-25 |
Taro Pharmaceutical Industries Ltd. |
Taste masking spill-resistant formulation
|
DE60239752D1
(de)
*
|
2001-10-22 |
2011-05-26 |
Taro Pharma Ind |
Den geschmack verdeckende auslaufsichere formulierung
|
US20050143471A1
(en)
*
|
2001-10-22 |
2005-06-30 |
Shen Gao |
Taste masking spill-resistant formulation
|
EP1463440B1
(en)
*
|
2001-12-06 |
2009-12-02 |
Duke University |
Prevention of flap necrosis in plastic surgery
|
MXPA04007438A
(es)
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
|
US20030166732A1
(en)
*
|
2002-02-27 |
2003-09-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
|
WO2003105804A1
(en)
*
|
2002-06-17 |
2003-12-24 |
Taro Pharmaceuticals U.S.A, Inc. |
Ibuprofen suspension
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US8481000B2
(en)
*
|
2003-01-31 |
2013-07-09 |
Simply Thick, Llc |
Thickened beverages for dysphagia
|
EP1653927B1
(en)
*
|
2003-08-04 |
2012-01-11 |
Bend Research, Inc. |
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
|
US7201920B2
(en)
*
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
US20080255104A1
(en)
*
|
2004-05-04 |
2008-10-16 |
Equitech Corporation |
Nsaid Compositions
|
CA2569958C
(en)
|
2004-06-12 |
2016-03-22 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
WO2006058140A2
(en)
*
|
2004-11-24 |
2006-06-01 |
Algorx Pharmaceuticals, Inc. |
Capsaicinoid gel formulation and uses thereof
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US20070112589A1
(en)
*
|
2005-11-17 |
2007-05-17 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
User interface for providing assistance related to health
|
US20070119928A1
(en)
*
|
2005-11-17 |
2007-05-31 |
Jung Edward K |
Generating a nutraceutical request from an inventory
|
US8532938B2
(en)
*
|
2005-11-17 |
2013-09-10 |
The Invention Science Fund I, Llc |
Testing-dependent administration of a nutraceutical
|
US20070112592A1
(en)
*
|
2005-11-17 |
2007-05-17 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Payments in providing assistance related to health
|
US20070112796A1
(en)
*
|
2005-11-17 |
2007-05-17 |
Jung Edward K |
Research in providing assistance related to health
|
US10042980B2
(en)
*
|
2005-11-17 |
2018-08-07 |
Gearbox Llc |
Providing assistance related to health
|
US20070124219A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized nutraceutical selection and packaging
|
US20110145009A1
(en)
*
|
2005-11-30 |
2011-06-16 |
Jung Edward K Y |
Methods and systems related to transmission of nutraceutical associatd information
|
US20070174128A1
(en)
*
|
2005-11-30 |
2007-07-26 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
US20080004905A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems for analysis of nutraceutical associated components
|
US20070124176A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
US8297028B2
(en)
*
|
2006-06-14 |
2012-10-30 |
The Invention Science Fund I, Llc |
Individualized pharmaceutical selection and packaging
|
US7974856B2
(en)
*
|
2005-11-30 |
2011-07-05 |
The Invention Science Fund I, Llc |
Computational systems and methods related to nutraceuticals
|
US20080103746A1
(en)
*
|
2005-11-30 |
2008-05-01 |
Searete Llc, A Limited Liability Corporation |
Systems and methods for pathogen detection and response
|
US20070289258A1
(en)
*
|
2006-06-14 |
2007-12-20 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Individualized pharmaceutical selection and packaging
|
US7827042B2
(en)
*
|
2005-11-30 |
2010-11-02 |
The Invention Science Fund I, Inc |
Methods and systems related to transmission of nutraceutical associated information
|
US20080114577A1
(en)
*
|
2005-11-30 |
2008-05-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems associated with nutraceutical related assays
|
US20080052114A1
(en)
*
|
2005-11-30 |
2008-02-28 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods related to nutraceuticals
|
US20080082272A1
(en)
*
|
2005-11-30 |
2008-04-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods related to nutraceuticals
|
US20080193919A1
(en)
*
|
2005-11-30 |
2008-08-14 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for receiving pathogen related information and responding
|
US20080033763A1
(en)
*
|
2005-11-30 |
2008-02-07 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems related to receiving nutraceutical associated information
|
US20070136092A1
(en)
*
|
2005-11-30 |
2007-06-14 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
US8340944B2
(en)
*
|
2005-11-30 |
2012-12-25 |
The Invention Science Fund I, Llc |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
US8000981B2
(en)
*
|
2005-11-30 |
2011-08-16 |
The Invention Science Fund I, Llc |
Methods and systems related to receiving nutraceutical associated information
|
US10296720B2
(en)
*
|
2005-11-30 |
2019-05-21 |
Gearbox Llc |
Computational systems and methods related to nutraceuticals
|
US20080004909A1
(en)
*
|
2005-11-30 |
2008-01-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems related to nutraceuticals
|
US7927787B2
(en)
|
2006-06-28 |
2011-04-19 |
The Invention Science Fund I, Llc |
Methods and systems for analysis of nutraceutical associated components
|
EP1964040A2
(en)
*
|
2005-12-20 |
2008-09-03 |
Searete LLC. |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
MY157620A
(en)
|
2006-01-31 |
2016-06-30 |
Cytochroma Dev Inc |
A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
|
AU2007266475B2
(en)
|
2006-05-30 |
2009-12-03 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20080086339A1
(en)
*
|
2006-06-23 |
2008-04-10 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Customized visual marking for medication labeling
|
US20080086338A1
(en)
*
|
2006-06-23 |
2008-04-10 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Customized visual marking for medication labeling
|
US20070299695A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Customized visual marking for medication labeling
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
KR20080076667A
(ko)
|
2007-02-15 |
2008-08-20 |
주식회사 중외제약 |
요변성 약학 조성물
|
CN105688191A
(zh)
|
2007-04-23 |
2016-06-22 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
CA2685936C
(en)
*
|
2007-05-07 |
2016-07-12 |
Clearly Superior, Inc. |
Food thickening agent, method for producing food thickening agent
|
US8001345B2
(en)
*
|
2007-05-10 |
2011-08-16 |
Dot Hill Systems Corporation |
Automatic triggering of backing store re-initialization
|
CA2691531C
(en)
|
2007-06-22 |
2016-11-01 |
Board Of Regents,The University Of Texas System |
Formation of stable submicron peptide or protein particles by thin film freezing
|
GB0714670D0
(en)
*
|
2007-07-27 |
2007-09-05 |
Ineos Healthcare Ltd |
Use
|
GB0720220D0
(en)
*
|
2007-10-16 |
2007-11-28 |
Ineos Healthcare Ltd |
Compound
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
GB0818473D0
(en)
|
2008-10-08 |
2008-11-12 |
Probio Nutraceuticals As |
Composition
|
CA2743789C
(en)
|
2008-11-16 |
2017-10-31 |
Board Of Regents, The Univesity Of Texas System |
Low viscosity highly concentrated suspensions
|
US8658628B2
(en)
*
|
2009-06-18 |
2014-02-25 |
Karan Y. Baucom |
Hormone delivery system and method
|
US9795617B2
(en)
|
2009-06-18 |
2017-10-24 |
Baucom Institute for Longevity and Life Enhancement, Inc. |
Hormone delivery system and method
|
GB0913525D0
(en)
|
2009-08-03 |
2009-09-16 |
Ineos Healthcare Ltd |
Method
|
MX352878B
(es)
|
2009-09-28 |
2017-12-13 |
Intarcia Therapeutics Inc |
Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
GB201001779D0
(en)
|
2010-02-04 |
2010-03-24 |
Ineos Healthcare Ltd |
Composition
|
SG10201510564PA
(en)
|
2010-12-22 |
2016-01-28 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
ES2581323T3
(es)
|
2010-12-23 |
2016-09-05 |
Purdue Pharma Lp |
Formas de dosificación oral sólida resistentes a alteraciones
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
ES2685608T3
(es)
*
|
2011-12-22 |
2018-10-10 |
Babolna Bio Ltd. |
Gel acuoso consumible para utilización en el control de plagas, dispositivo de control de plagas que comprende un gel acuoso, y utilización de un gel acuoso en un dispositivo de control de plagas y en un procedimiento de control de plagas
|
DK2911530T3
(en)
*
|
2012-10-25 |
2017-03-20 |
Nestec Sa |
INCORPORATED BITTER PEPTIDES, PROCEDURES FOR ENCOURAGING BITTER PEPTIDES, AND NUTRITIONAL COMPOSITIONS INCLUDING THE CONTAINED BITTER PEPTIDES
|
US8550131B1
(en)
|
2013-01-02 |
2013-10-08 |
Liquid Squeeze, LLC |
Liquid dispensing device, system and method
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9101156B2
(en)
|
2013-03-15 |
2015-08-11 |
Kent Precision Foods Group, Inc. |
Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CN113598842A
(zh)
|
2015-06-03 |
2021-11-05 |
因塔西亚制药公司 |
植入物放置和移除系统
|
PT3319596T
(pt)
*
|
2015-07-09 |
2024-01-17 |
Uniwell Laboratories Llc |
Composições farmacêuticas
|
MX2018014016A
(es)
|
2016-05-16 |
2019-08-01 |
Intarcia Therapeutics Inc |
Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
EP3565580B1
(en)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
|
US11751594B2
(en)
|
2020-10-22 |
2023-09-12 |
Grain Processing Corporation |
Food thickener composition and method
|